WOS期刊SCI分区是指SCI官方(Web of
Science)为每个学科内的期刊按照IF数值排序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2022-2023年最新版)
PHARMACOLOGY & PHARMACY
Q1
测一测你投这本期刊的成功率
【官方推荐】国内首个期刊投稿预测系统,多维度分析投稿成功率,助你精准决策
12481
人已预测
期刊介绍
Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. We provide a venue through which specialists across disciplines can rapidly exchange information in health sciences that pertains to modern pharmacological topics. The journal publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
来源期刊:Pharmacological research
DOI:10.1016/j.phrs.2018.11.035
Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases.
来源期刊:Pharmacological research
DOI:10.1016/j.phrs.2019.02.009
Clinical evidence on the effects of saffron (Crocus sativus L.) on cardiovascular risk factors: A systematic review meta‐analysis
来源期刊:Pharmacological Research
DOI:10.1016/j.phrs.2018.11.038
The therapeutic role of long non‐coding RNAs in human diseases: A focus on the recent insights into autophagy
来源期刊:Pharmacological Research
DOI:10.1016/j.phrs.2019.02.010
Hydrogen sulfide stabilizes atherosclerotic plaques in apolipoprotein E knockout mice.
来源期刊:Pharmacological research
DOI:10.1016/j.phrs.2019.04.006
已经到底了~
测一测你投这本期刊的成功率
【官方推荐】国内首个期刊投稿预测系统,多维度分析投稿成功率,助你精准决策
12481
人已预测
鹿粉166907
2022-11-08 18:23:53
received 30 january 2021, major revision 3 march 2021, revised 2 april 2021, accepted 12 april 2021, available online 16 april 2021, proofs 22 april 2021.
投的临床用药观察性研究,审稿人意见非常中肯,所提的问题比较明确,会给出具体解决的建议,大修一次后就直接接收了,速度快,效率高,国人文章不少,比较友好。
鹿粉135225
2022-11-08 18:23:53
5.3 submitted to journal
5.4 with editor (此阶段包含inviting reviewers时间,只有inviting reviewers接受邀请才会进入review阶段)
5.10 under review
6.10 required reviews completed
6.12 decision in process
6.14 major revise (20天期限)
7.2 resubmitted to journal
7.3 with editor (此阶段包含inviting reviewers时间,只有inviting reviewers接受邀请才会进入review阶段)
7.11 under review
7.20 required reviews completed
7.20 decision in process
7.23 accept
7.23 pre-proof online (doi )
7.27 final version published online
8.23 web of science核心集可检索收录
7.4 投稿7.5 拒稿,建议修改标题,并补充7.12 修改后Submitted to Journal7.12 With Editor7.12 Under Review8.12 三个审稿人意见返回,Required Reviews Completed,最后回了三个意见8.12 晚上 Major Revise (20天期限)8.30 With Editor9.1 Under Review9.3 两个审稿人意见返回9.3 Decision in Process9.8 Accept投稿后拒稿在次投稿,希望可以给大家参考一下。
鹿粉147411
2022-08-29 00:00:00
请问友友们,这个杂志接收meta分析嘛
鹿粉132242
2022-07-17 00:00:00
5.3 Submitted to Journal5.4 With Editor (此阶段包含inviting reviewers时间,只有inviting reviewers接受邀请才会进入Review阶段)5.10 Under Review6.10 Required Reviews Completed6.12 Decision in Process6.14 Major Revise (20天期限)7.2 Resubmitted to Journal7.3 With Editor (此阶段包含inviting reviewers时间,只有inviting reviewers接受邀请才会进入Review阶段)7.11 Under Review7.20 Required Reviews Completed7.20 Decision in Process7.23 Accept7.23 Pre-proof online (DOI )要点:1.Pharmacological Research期刊的审稿效率很高,投稿后Editor如果觉得文章质量不高会在当天拒稿,如果投稿当天或者第二天没有decision inprocess,那文章基本上进入Review invitations sent环节,但投稿状态仍然显示With Editor,只有等inviting reviewers同意审稿,投稿状态才会变成Under Review。2.一审1个月左右,编辑和评审对国人友好,文章语言没经过润色,但返修时编辑和评审都没提文章语言的问题。3.文章在返修提交时候,系统里会必须要求上传Graphical abstract figure以及Western blot的uncropped images,可以不是全膜,只要把显影结果的条带贴上去并且标出清晰的Marker位置和分子量并将文章全部的Western blot uncropped images保存为word或者pdf上传以供审核祝各位的Paper早日Accept !!!
The authors should include all the "raw" images of western blots and Co-IP (the full image rather than the cut strips) as supplemental data. All the data points behind the bar-graphs should also be attached as readable text.
Received at Editorial Office 17 Apr 2021Article revised 8 Jul 2021Article accepted for publication 9 Aug 2021审稿人非常好且严肃认真,直接指出了当初发现而又懒得改的一些问题,编辑效率很高,值得推荐!